BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 23837154)

  • 1. Topical treatment of onychomycosis with efinaconazole solution 10%.
    Rich P
    Cutis; 2013 Jun; 91(6):305-7. PubMed ID: 23837154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Lipner SR; Scher RK
    Expert Rev Clin Pharmacol; 2015; 8(6):719-31. PubMed ID: 26325488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors for Complete Cure Following Treatment of Mild and Moderate Toenail Onychomycosis With Efinaconazole Topical Solution 10.
    Jellinek NJ; Korotzer A
    J Drugs Dermatol; 2015 Aug; 14(8):871-5. PubMed ID: 26267732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
    Tschen EH; Bucko AD; Oizumi N; Kawabata H; Olin JT; Pillai R
    J Drugs Dermatol; 2013 Feb; 12(2):186-92. PubMed ID: 23377392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
    Vlahovic TC; Joseph WS
    J Drugs Dermatol; 2014 Oct; 13(10):1186-90. PubMed ID: 25607552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
    Pollak RA
    J Am Podiatr Med Assoc; 2014 Nov; 104(6):568-73. PubMed ID: 25514267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution.
    Cantrell W; Canavan T; Elewski B
    J Drugs Dermatol; 2015 May; 14(5):524-6. PubMed ID: 25942674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical treatment of onychomycosis as a realistic option to systemic therapy: a case report.
    Gupta AK
    J Am Podiatr Med Assoc; 2014; 104(1):115-7. PubMed ID: 24504588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis.
    Tosti A
    Cutis; 2013 Oct; 92(4):203-8. PubMed ID: 24195094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients.
    Eichenfield LF; Elewski B; Sugarman JL; Rosen T; Vlahovic TC; Gupta AK; Stein Gold L; Pillai R; Guenin E
    J Drugs Dermatol; 2020 Sep; 19(9):867-872. PubMed ID: 33026753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
    Elewski BE; Rich P; Pollak R; Pariser DM; Watanabe S; Senda H; Ieda C; Smith K; Pillai R; Ramakrishna T; Olin JT
    J Am Acad Dermatol; 2013 Apr; 68(4):600-608. PubMed ID: 23177180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early.
    Rich P
    J Drugs Dermatol; 2015 Jan; 14(1):58-62. PubMed ID: 25607909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space.
    Elewski BE; Pollak RA; Pillai R; Olin JT
    J Drugs Dermatol; 2014 Nov; 13(11):1394-8. PubMed ID: 25607708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efinaconazole solution 10% for treatment of toenail onychomycosis in Latino patients.
    Cook-Bolden FE; Lin T
    Cutis; 2017 Apr; 99(4):286-289. PubMed ID: 28492600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
    Gupta AK; Elewski BE; Sugarman JL; Ieda C; Kawabata H; Kang R; Pillai R; Olin JT; Watanabe S
    J Drugs Dermatol; 2014 Jul; 13(7):815-20. PubMed ID: 25007364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efinaconazole 10% nail solution: a new topical treatment with broad antifungal activity for onychomycosis monotherapy.
    Gupta AK; Paquet M
    J Cutan Med Surg; 2014; 18(3):151-5. PubMed ID: 24800702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole.
    Pollak RA; Ilie C
    J Drugs Dermatol; 2017 Dec; 16(12):1269-1273. PubMed ID: 29240863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of gender as a clinically relevant outcome variable in the treatment of onychomycosis with efinaconazole topical solution 10.
    Rosen T
    Cutis; 2015 Sep; 96(3):197-201. PubMed ID: 26562270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim Analysis.
    Gupta AK; Cooper EA
    Skin Therapy Lett; 2021 Jan; 26(1):5-10. PubMed ID: 33539062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.